Publicaciones (76) Publicaciones en las que ha participado algún/a investigador/a

2002

  1. A randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: The ADHOC trial

    HIV Medicine, Vol. 3, Núm. 4, pp. 229-238

  2. Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine

    AIDS, Vol. 16, Núm. 17, pp. 2352-2354

  3. Aplicación de la gestión por procesos a la sunidades de atención al usuario.

    Revista de calidad asistencial, Vol. 17, Núm. 6, pp. 353-357

  4. Application of process management in nephrology. Hemodialysis process management

    Nefrología : publicación oficial de la Sociedad Española Nefrologia, Vol. 22, Núm. 4, pp. 329-339

  5. Aspectos sociodemográficos de los intentos de suicidio

    Actas Espanolas de Psiquiatria, Vol. 30, Núm. 2, pp. 112-119

  6. Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts

    Journal of Infectious Diseases, Vol. 186, Núm. 2, pp. 189-197

  7. Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates

    Biomaterials, Vol. 23, Núm. 18, pp. 3825-3831

  8. Care of patients with chronic hepatitis C and HIV co-infection: Recommendations from the HIV-HCV International Panel

    AIDS, Vol. 16, Núm. 6, pp. 813-828

  9. Characterization of distinct apoptotic changes induced by okadaic acid and yessotoxin in the BE(2)-M17 neuroblastoma cell line

    Toxicology in Vitro, Vol. 16, Núm. 1, pp. 23-31

  10. Clinical value of immunological monitoring of minimal residual disease in acute lymphoblastic leukaemia after allogeneic transplantation

    British Journal of Haematology, Vol. 116, Núm. 3, pp. 686-694

  11. Clonal evolution of blasts in an elderly patient with CD56+ relapsed acute promyelocytic leukemia

    American Journal of Hematology, Vol. 69, Núm. 1, pp. 59-63

  12. Comparison of the efficacy, safety and predictive value of HIV genotyping using distinct ritonavir-boosted protease inhibitors

    International Journal of Antimicrobial Agents, Vol. 20, Núm. 6, pp. 438-443

  13. Complex cytogenetic abnormalities including telomeric associations and MEN1 mutation in a pediatric ependymoma

    Cancer Genetics and Cytogenetics, Vol. 138, Núm. 2, pp. 107-110

  14. Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid

    AIDS, Vol. 16, Núm. 13, pp. 1830-1832

  15. Dependency and unmet need of care in older people in a health area of Saragossa, Spain

    Revista Espanola de Salud Publica, Vol. 76, Núm. 3, pp. 215-226

  16. Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors

    AIDS Research and Human Retroviruses, Vol. 18, Núm. 18, pp. 1379-1388

  17. Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides

    AIDS, Vol. 16, Núm. 2, pp. 245-249

  18. Does an increase in nevirapine plasma levels cause complete virologic suppression in patients experiencing early virologic failure?

    HIV Clinical Trials, Vol. 3, Núm. 6, pp. 463-474

  19. Early onset of evans syndrome following autologous peripheral blood progenitor cell transplantation in a child.

    Haematologica, Vol. 87, Núm. 5

  20. Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia

    AIDS, Vol. 16, Núm. 15, pp. 2079-2081